|
LPHD characteristics
| |
West incl. Berlin
|
East
|
Total
|
|---|
|
Population size covered
|
<250,000
|
10
|
4
|
14
|
|
250,000- < 500,000
|
4
|
0
|
4
|
|
≥500,000
|
8
|
2
|
10
|
|
Monthly number of attendees
|
1–25
|
8
|
1
|
9
|
|
26–50
|
1
|
2
|
3
|
|
51–100
|
5
|
2
|
7
|
|
>100
|
7
|
1
|
8
|
|
Missing
|
1
|
0
|
1
|
|
Proportion of FSW among attendees
|
1–25%
|
10
|
4
|
14
|
|
26–50%
|
3
|
0
|
3
|
|
51–75%
|
2
|
0
|
2
|
|
76–100%
|
6
|
2
|
8
|
|
Missing
|
1
|
0
|
1
|
|
Number of STI tests offereda
|
Only HIV-test
|
1
|
0
|
1
|
|
HIV plus 2–6 STI tests
|
5
|
1
|
6
|
|
HIV plus 7 STI tests
|
16
|
5
|
21
|
- aSTI tests: HIV, syphilis, Chlamydia trachomatis, Neisseria gonorrhoea, Trichomonas vaginalis, hepatitis A, hepatitis B, hepatitis C
